Global Veterinary Drugs Contract Manufacturing Market Growth (Status and Outlook) 2025-2031

The global Veterinary Drugs Contract Manufacturing market size is predicted to grow from US$ 3498 million in 2025 to US$ 4909 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.

Veterinary drug contract manufacturing refers to a form of cooperation in which a veterinary drug business enterprise signs a contract with a veterinary drug manufacturer, and the manufacturer produces veterinary drug products in accordance with the contract, while the veterinary drug business enterprise is responsible for product sales. The veterinary drug contract manufacturing model is conducive to improving the utilization rate of existing resources on a larger scale and promoting the refinement, specialization and scale of the veterinary drug industry chain. It enables veterinary drug business enterprises to focus on core businesses such as marketing, sales and services, while handing over the production process to manufacturers with professional knowledge and experience, thereby improving overall operational efficiency.

United States market for Veterinary Drugs Contract Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Veterinary Drugs Contract Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Veterinary Drugs Contract Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Veterinary Drugs Contract Manufacturing players cover Vetio, AlphaVet Export, Fabbrica Italiana Sintetici, Veto-pharma, Parnell, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Veterinary Drugs Contract Manufacturing Industry Forecast” looks at past sales and reviews total world Veterinary Drugs Contract Manufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Drugs Contract Manufacturing sales for 2025 through 2031. With Veterinary Drugs Contract Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drugs Contract Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Drugs Contract Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Drugs Contract Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Drugs Contract Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drugs Contract Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drugs Contract Manufacturing.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drugs Contract Manufacturing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others

Segmentation by Application:
Pets
Cattle
Poultry
Swine
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Vetio
AlphaVet Export
Fabbrica Italiana Sintetici
Veto-pharma
Parnell
Medical Products Laboratories
Univet
Oxi Pharma
Sterling Pharmaceutical Services
ACME Drugs
Kela Health
Friulchem S.p.A.
Sypharma Pty Ltd
Safapac
Custom Veterinary Services
LABIANA
Nedulix Biotech Private Limited
Argenta Global
Altar Life Sciences

Please note: The report will take approximately 2 business days to prepare and deliver. Show more